Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin versus linagliptin for renal effects in diabetic nephropathy
ChiCTR-IPR-15006340Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diabetic glomerulosclerosis comparing Saxagliptin group with Linagliptin group (2 arms). Primary endpoints: Urinary albumin creatinine ratio, Transferrin and 2 more. Planned start May 2015; status: not yet recruiting.
02
Drugs
saxagliptinlinagliptin
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR-IPR-15006340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006340.